1.33
-0.02(-1.48%)
Currency In USD
| Previous Close | 1.35 |
| Open | 1.35 |
| Day High | 1.37 |
| Day Low | 1.29 |
| 52-Week High | 274.5 |
| 52-Week Low | 1.29 |
| Volume | 143,361 |
| Average Volume | 368,471 |
| Market Cap | 4.06M |
| PE | -0.01 |
| EPS | -142.21 |
| Moving Average 50 Days | 2.04 |
| Moving Average 200 Days | 38.52 |
| Change | -0.02 |
If you invested $1000 in Conduit Pharmaceuticals Inc. (CDT) since IPO date, it would be worth $0.09 as of August 31, 2025 at a share price of $1.33. Whereas If you bought $1000 worth of Conduit Pharmaceuticals Inc. (CDT) shares 2 years ago, it would be worth $0.08 as of August 31, 2025 at a share price of $1.33.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
GlobeNewswire Inc.
Aug 26, 2025 12:30 PM GMT
Using AI, CDT Equity Inc. identifies a novel therapeutic indication for its lead programmes, supported by successful pre-clinical trial dataNAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 26, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT)
Conduit to Change Name to CDT Equity Inc.
GlobeNewswire Inc.
Aug 05, 2025 12:30 PM GMT
Name change to CDT Equity Inc. reflects evolution of strategy and focus on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation, strategic partnerships and out-licensing NAPLES, Fla. and CAMBRIDGE, Uni
Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy
GlobeNewswire Inc.
Jul 08, 2025 12:30 PM GMT
Independent advisor appointed to assess feasibility and strategic benefit of a partial cryptocurrency-based treasury reserveInitiative aims to diversify capital positioning while retaining focus on IP-driven pharmaceutical development NAPLES, Fla. an